Tumor antigens recognized by T cells

被引：469

作者：

Boon, T ^{[1
]}

Coulie, PG ^{[1
]}

VandenEynde, B ^{[1
]}

机构：

[1] UNIV CATHOLIQUE LOUVAIN,CELLULAR GENET UNIT,B-1200 BRUSSELS,BELGIUM

来源：

IMMUNOLOGY TODAY | 1997年 / 18卷 / 06期

关键词：

D O I：

10.1016/S0167-5699(97)80020-5

中图分类号：

R392 [医学免疫学]; Q939.91 [免疫学];

学科分类号：

100102 ;

摘要：

A large number of human tumor-specific antigens have been identified. Here, Thierry Boon and colleagues explain that the priority now is to demonstrate that immunization against them is clinically valuable.

引用

页码：267 / 268

页数：2

共 15 条

[1] Phenotypic analysis of antigen-specific T lymphocytes
Altman, JD
Moss, PAH
Goulder, PJR
Barouch, DH
McHeyzerWilliams, MG
Bell, JI
McMichael, AJ
Davis, MM
[J]. SCIENCE, 1996, 274 (5284) : 94 - 96
[2] The activation of human gene MAGE-1 in tumor cells is correlated with genome-wide demethylation
DeSmet, C
DeBacker, O
Faraoni, I
Lurquin, C
Brasseur, F
Boon, T
[J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1996, 93 (14) : 7149 - 7153
[3] IDENTIFICATION OF AN IMMUNODOMINANT PEPTIDE OF HER-2/NEU PROTOONCOGENE RECOGNIZED BY OVARIAN TUMOR-SPECIFIC CYTOTOXIC T-LYMPHOCYTE LINES
FISK, B
BLEVINS, TL
WHARTON, JT
IOANNIDES, CG
[J]. JOURNAL OF EXPERIMENTAL MEDICINE, 1995, 181 (06) : 2109 - 2117
[4] Melanoma cell expression of Fas(Apo-1/CD95) ligand: Implications for tumor immune escape
Hahne, M
Rimoldi, D
Schroter, M
Romero, P
Schreier, M
French, LE
Schneider, P
Bornand, T
Fontana, A
Lienard, D
Cerottini, JC
Tschopp, J
[J]. SCIENCE, 1996, 274 (5291) : 1363 - 1366
[5] Vaccination of patients with B-cell lymphoma using autologous antigen-pulsed dendritic cells
Hsu, FJ
Benike, C
Fagnoni, F
Liles, TM
Czerwinski, D
Taidi, B
Engleman, EG
Levy, R
[J]. NATURE MEDICINE, 1996, 2 (01) : 52 - 58
[6] Characterization of an antigen that is recognized on a melanoma showing partial HLA loss by CTL expressing an NK inhibitory receptor
Ikeda, H
Lethe, B
Lehmann, F
VanBaren, N
Baurain, JF
DeSmet, C
Chambost, H
Vitale, M
Moretta, A
Boon, T
Coulie, PG
[J]. IMMUNITY, 1997, 6 (02) : 199 - 208
[7] Tumor regression responses in melanoma patients treated with a peptide encoded by gene MAGE-3
Marchand, M
Weynants, P
Rankin, E
Arienti, F
Belli, F
Parmiani, G
Cascinelli, N
Bourlond, A
Vanwijck, R
Humblet, Y
Canon, JL
Laurent, C
Naeyaert, JM
Plagne, R
Deraemaeker, R
Knuth, A
Jager, E
Brasseur, F
Herman, J
Coulie, PG
Boon, T
[J]. INTERNATIONAL JOURNAL OF CANCER, 1995, 63 (06) : 883 - 885
[8] INFLUENCE OF INTERLEUKIN-12 ON P53 PEPTIDE VACCINATION AGAINST ESTABLISHED METH-A SARCOMA
NOGUCHI, Y
RICHARDS, EC
CHEN, YT
OLD, LJ
[J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1995, 92 (06) : 2219 - 2223
[9] HUMAN NEOPLASMS ELICIT MULTIPLE SPECIFIC IMMUNE-RESPONSES IN THE AUTOLOGOUS HOST
SAHIN, U
TURECI, O
SCHMITT, H
COCHLOVIUS, B
JOHANNES, T
SCHMITS, R
STENNER, F
LUO, GR
SCHOBERT, I
PFREUNDSCHUH, M
[J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1995, 92 (25) : 11810 - 11813
[10] Recognition of BCR-ABL positive leukemic blasts by human CD4(+)T cells elicited by primary in vitro immunization with a BCR-ABL breakpoint peptide
tenBosch, GJA
Joosten, AM
Kessler, JH
Melief, CJM
Leeksma, OC
[J]. BLOOD, 1996, 88 (09) : 3522 - 3527

← 1 2 →